findmyKOL
Clinical trialNCT06053580RecruitingPhase 2Interventional

Repurposing Valsartan May Protect Against Pulmonary Hypertension

SponsorUniversity of WashingtonEnrollment60Pulmonary Arterial HypertensionPulmonary Vascular DisorderRight Heart FailureRight Ventricular Dysfunction
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a Phase 2, single-center, randomized placebo controlled trial of valsartan (an angiotensin receptor blocker) in adults with pulmonary arterial hypertension. The study will evaluate the safety and clinical efficacy of a 24-week course of valsartan.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

1 registered facility, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • University of Washington Medical Center

    Seattle, Washington, United States

    Lia M Barros, DNPPeter J Leary, MD, PhDSam G Rayner, MDYonatan Buber, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

PlaceboValsartan →
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
28 Feb 2024
Primary completion
1 Jul 2027
Completion
1 Jul 2027
Last update posted
4 May 2026
Registered enrollment
60
Registry id
NCT06053580
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.